Physician
Xie, Qiang
Xie, Qiang was paid $57K by Medicaid between Jun 2019 and Oct 2023, across 15 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 67% of everything it billed.
33Billing provider infoXIE, QIANG
BROOKLYN, NY 11203
BROOKLYN, NY 11203
33aNPI1427285386assigned 06/18/2009
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$57K
24GClaims2,954
24DCodes billed15
24AFirst – last monthJun 2019 – Oct 2023
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in New York
Rank by total paid#46 of 94
Median peer was paid$46K
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 148 | $1K | |
| 2020 | 222 | $2K | |
| 2021 | 1,256 | $29K | |
| 2022 | 915 | $21K | |
| 2023 | 413 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 67% | 930 | 779 | $38K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 13% | 749 | 614 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.5% | 151 | 151 | $3K |
| 80061 | Lipid panel | 4.2% | 318 | 317 | $2K |
| 80050 | General health panel | 3.1% | 82 | 82 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.1% | 321 | 321 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 23 | 23 | $950.36 |
| 82607 | 1.5% | 100 | 100 | $849.29 | |
| 80053 | Comprehensive metabolic panel | <1% | 49 | 49 | $260.73 |
| 81001 | <1% | 150 | 149 | $253.87 | |
| 86769 | <1% | 12 | 12 | $208.92 | |
| 84439 | <1% | 28 | 28 | $139.46 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.